In this inaugural interview for the JLS Podcast, we speak with Jonathan Sporn — CEO of Gilgamesh Pharmaceuticals, Harvard MD, and former Pfizer researcher. From partnering with Columbia University chemists to designing novel psychedelic-inspired molecules to leading one of the largest biotech deals in history with AbbVie, Sporn brings vision, innovation, and scientific rigor to the frontier of psychedelic medicine. Tune in to explore the cutting edge of drug development, neuroplasticity, and transformative therapies.Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:https://www.patreon.com/c/thelastalchemist

Ver todos los episodios